- Recent Funding
- Investors
- Angelini Ventures
Angelini Ventures portfolio
Angelini Ventures has 14 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.
About this page
It is a corporate venture investor based in Rome, IT, founded in 2021. It led 3 of the 9 rounds it joined. Its most recent investment on record is MMI's $125M Series B+ round in October 2026, alongside S3 Ventures and BioStar Capital. By category, its portfolio leans toward Health and bio (14) and Robotics and hardware (2). It has co-invested with Kurma Partners, Kerna Ventures and Indaco Venture Partners, most often Kurma Partners (2 rounds).
About Angelini Ventures
What Angelini Ventures invests in
- Health and bio · 14 · 100%
- Robotics and hardware · 2 · 14%
- Education · 1 · 7%
Angelini Ventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $125M | S3 Ventures, BioStar Capital (lead) | ||
| Series A · $58M · lead | European Investment Bank Group, Epidarex Capital, Kerna Ventures +6 | ||
| Seed · $45M | Crescent Enterprises, Evotec, XGEN Venture +6 | ||
| Series B+ · $90M | Janus Henderson Investors (lead), Duquesne Family Office, Octagon Capital Advisors (lead) +5 | ||
| Series A · $39M | Apollo Health Ventures, Eli Lilly, Dolby Family Ventures +5 | ||
| Series B+ · $45M · lead | Boehringer Ingelheim Venture Fund, Highlight Capital, EDBI +4 | ||
| Series B+ · $37M · lead | EQT Health Economics, 15th Rock, Nexus NeuroTech (lead) +5 | ||
| Series B+ · $40M | Treo Ventures, OrbiMed, Sectoral Asset Management (lead) +2 |
How Angelini Ventures invests
Angelini Ventures portfolio companies
MMMI$125MSeries B+ · Oct 2026
RRougeTx$58MSeries A · Oct 2026
AAptadir Therapeutics$45MSeed · Sep 2026
EEpicrispr Biotechnologies$90MSeries B+ · Aug 2026
TTherini Bio$39MSeries A · May 2025
NNuevocor$45MSeries B+ · May 2025
NNobi$37MSeries B+ · Feb 2025
NNoctrix Health$40MSeries B+ · Jan 2024
FFreya Biosciences$38MSeries A · Dec 2023
AAdcytherixbacker
EElkedoniabacker
CCoMindbacker
NNouscombacker
VVantisbacker
| Company | Round with Angelini Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $125M | $310M | Oct 8, 2026 Series B+ |
Health and bio |
Series A · $58M · lead | $58M | Oct 6, 2026 Series A |
Health and bio |
Seed · $45M | $45M | Sep 29, 2026 Seed |
Health and bio |
Series B+ · $90M | $158M | Aug 11, 2026 Series B+ |
Health and bio |
Series A · $39M | $56M | May 21, 2026 Series A |
Health and bio |
Series B+ · $45M · lead | $69M | May 6, 2025 Series B+ |
Health and bio |
Series B+ · $37M · lead | $41M | Feb 4, 2025 Series B+ |
Health and bio |
Series B+ · $40M | $73.5M | Sep 2, 2025 round |
Health and bio |
Series A · $38M | $38M | Nov 19, 2024 Series A |
Health and bio |
backer | undisclosed | Oct 16, 2025 Series A |
Health and bio |
backer | $13M | Jul 12, 2025 Seed |
Health and bio |
backer | undisclosed | — |
Health and bio |
backer | $267.56M | Oct 19, 2026 Series B+ |
Health and bio |
backer | $4.58M | Mar 12, 2025 Series A |
Most frequent co-investors
KKurma Partners2 shared rounds · last Oct 6, 2026
KKerna Ventures2 shared rounds · last Oct 6, 2026
IIndaco Venture Partners2 shared rounds · last Sep 29, 2026
SSanofi Ventures2 shared rounds · last Aug 11, 2026
SS3 Ventures1 shared round · last Oct 8, 2026
BBioStar Capital1 shared round · last Oct 8, 2026
EEuropean Investment Bank Group1 shared round · last Oct 6, 2026
BBioGeneration Ventures1 shared round · last Oct 6, 2026
RROM Utrecht Region1 shared round · last Oct 6, 2026
EEpidarex Capital1 shared round · last Oct 6, 2026
VVesalius Biocapital Partners1 shared round · last Oct 6, 2026
Pp531 shared round · last Oct 6, 2026
Similar investors
OOptum Ventures16 companies · 4 deals in 12 mo
RRegeneron Ventures10 companies · 5 deals in 12 mo
UUPMC Enterprises10 companies · 4 deals in 12 mo
PPfizer Venture Investments20 companies · 6 deals in 12 mo
MM Ventures21 companies · 7 deals in 12 mo
NNovartis Venture Fund21 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 9 rounds on Recent Funding that name Angelini Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Angelini Ventures, which is a subset of its real portfolio. API: /api/v1/investors/angelini-ventures (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy